BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27021493)

  • 21. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of incidental colorectal pathology on positron emission tomography/computed tomography.
    Mui M; Akhurst T; Warrier SK; Lynch AC; Heriot AG
    ANZ J Surg; 2018 Mar; 88(3):E122-E126. PubMed ID: 27580915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Ann Nucl Med; 2007 Nov; 21(9):481-98. PubMed ID: 18030580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report.
    Terauchi T; Murano T; Daisaki H; Kanou D; Shoda H; Kakinuma R; Hamashima C; Moriyama N; Kakizoe T
    Ann Nucl Med; 2008 Jun; 22(5):379-85. PubMed ID: 18600415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of 18-fluoro deoxy glucose-positron emission tomography computed tomography for the detection of colonic neoplasia proximal to obstructing colorectal cancer.
    Hojo D; Tanaka T; Takahashi M; Murono K; Emoto S; Kaneko M; Sasaki K; Otani K; Nishikawa T; Hata K; Kawai K; Momose T; Nozawa H
    Medicine (Baltimore); 2018 Aug; 97(31):e11655. PubMed ID: 30075550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidental colonic 18F-fluorodeoxyglucose uptake: do we need colonoscopy for patients with focal uptake confined to the left-sided colon?
    Lee C; Koh SJ; Kim JW; Lee KL; Im JP; Kim SG; Kim JS; Jung HC; Kim BG
    Dig Dis Sci; 2013 Jan; 58(1):229-35. PubMed ID: 22886593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of 18F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer.
    Choi BW; Kim HW; Won KS; Song BI; Cho KB; Bae SU
    Medicine (Baltimore); 2016 Sep; 95(36):e4741. PubMed ID: 27603371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
    Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
    Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Clin Breast Cancer; 2015 Apr; 15(2):e139-46. PubMed ID: 25454690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential usefulness of (18)F-FDG PET/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults.
    Hwang JP; Woo SK; Yoon SY; Jeong SY
    Ann Nucl Med; 2015 Feb; 29(2):157-63. PubMed ID: 25358843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study.
    van Kouwen MC; Nagengast FM; Jansen JB; Oyen WJ; Drenth JP
    J Clin Oncol; 2005 Jun; 23(16):3713-7. PubMed ID: 15923568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental colorectal FDG uptake on PET/CT scan and lesions observed during subsequent colonoscopy: a systematic review.
    Kousgaard SJ; Thorlacius-Ussing O
    Tech Coloproctol; 2017 Jul; 21(7):521-529. PubMed ID: 28620878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature.
    Treglia G; Calcagni ML; Rufini V; Leccisotti L; Meduri GM; Spitilli MG; Dambra DP; De Gaetano AM; Giordano A
    Colorectal Dis; 2012 Feb; 14(2):174-80. PubMed ID: 21689289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between incidental focal colorectal FDG uptake on PET/CT and colonoscopic and histopathological results.
    Albertsen LN; Jaensch C; Tornbjerg SM; Teil J; Madsen AH
    Scand J Gastroenterol; 2022 Feb; 57(2):246-252. PubMed ID: 34735311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer.
    Shyn PB; Madan R; Wu C; Erturk SM; Silverman SG
    AJR Am J Roentgenol; 2010 Feb; 194(2):414-21. PubMed ID: 20093604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of laxative-augmented contrast medium in the evaluation of colorectal foci at FDG PET.
    Chen YK; Chen JH; Tsui CC; Chou HH; Cheng RH; Chiu JS
    Radiology; 2011 May; 259(2):525-33. PubMed ID: 21406631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of preoperative whole-body positron emission tomography with MDCT in patients with primary colorectal cancer.
    Akiyoshi T; Oya M; Fujimoto Y; Kuroyanagi H; Ueno M; Yamaguchi T; Koyama M; Tanaka H; Matsueda K; Muto T
    Colorectal Dis; 2009 Jun; 11(5):464-9. PubMed ID: 18637927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.
    Zhang C; Chen Y; Xue H; Zheng P; Tong J; Liu J; Sun X; Huang G
    Int J Cancer; 2009 Jan; 124(1):167-73. PubMed ID: 18844237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.